We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Forecasts Earnings Growth in 2007 From New Drugs
Merck Forecasts Earnings Growth in 2007 From New Drugs
December 6, 2006
Merck continues to predict growth in its earnings per share (EPS) for 2007, due to high expectations for its new products and savings from a global restructuring plan.